论文信息 - Utility of COVID‐19 antigen testing in the emergency department

Utility of COVID‐19 antigen testing in the emergency department

The BinaxNOW coronavirus disease 2019 (COVID‐19) Ag Card test (Abbott Diagnostics Scarborough, Inc.) is a lateral flow immunochromatographic point‐of‐care test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) nucleocapsid protein antigen. It provides results from nasal swabs in 15 minutes. Our purpose was to determine its sensitivity and specificity for a COVID‐19 diagnosis.

[1] M. M. van der Eerden,et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) , 2021, Nature communications.

[2] G. Blanchard-Rohner,et al. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series , 2020, mSphere.

[3] Malik Peiris,et al. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease , 2020, Emerging infectious diseases.

[4] M. Raad,et al. COVID-19: A Multidisciplinary Review , 2020, Frontiers in Public Health.

[5] P. V. Van Caeseele,et al. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples , 2020, Clinical Infectious Diseases.

[6] H. Yen,et al. Peer Review File Manuscript Title: Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters , 2020 .

[7] D. Raoult,et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[8] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[9] L Rampal,et al. Coronavirus disease (COVID-19) pandemic. , 2020, The Medical journal of Malaysia.

[10] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.